Personal information

No personal information available

Activities

Professional activities (1)

American Association for Cancer Research: Philadelphia, PA, US

2016 to present | Association Membership
Membership
Source: Self-asserted source
Yuming Guo

Works (24)

Data from G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway

2023-04-03 | Preprint
Contributors: Ting Sun; Keqiang Zhang; Rajendra P. Pangeni; Jun Wu; Wendong Li; Yong Du; Yuming Guo; Shyambabu Chaurasiya; Leonidas Arvanitis; Dan J. Raz
Source: check_circle
Crossref

Data from G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway

2023-04-03 | Preprint
Contributors: Ting Sun; Keqiang Zhang; Rajendra P. Pangeni; Jun Wu; Wendong Li; Yong Du; Yuming Guo; Shyambabu Chaurasiya; Leonidas Arvanitis; Dan J. Raz
Source: check_circle
Crossref

Supplementary Figures S1-S6 from G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway

2023-04-03 | Preprint
Contributors: Ting Sun; Keqiang Zhang; Rajendra P. Pangeni; Jun Wu; Wendong Li; Yong Du; Yuming Guo; Shyambabu Chaurasiya; Leonidas Arvanitis; Dan J. Raz
Source: check_circle
Crossref

Supplementary Figures S1-S6 from G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway

2023-04-03 | Preprint
Contributors: Ting Sun; Keqiang Zhang; Rajendra P. Pangeni; Jun Wu; Wendong Li; Yong Du; Yuming Guo; Shyambabu Chaurasiya; Leonidas Arvanitis; Dan J. Raz
Source: check_circle
Crossref

Data from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Data from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Figure 3 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Figure 3 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Figure legends from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Figure legends from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Materials and Methods from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Materials and Methods from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Table 1 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Supplementary Table 1 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

2023-03-31 | Preprint
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway

Clinical Colorectal Cancer
2021-03 | Journal article
Contributors: Jeremy Chuang; Chongkai Wang; Yuming Guo; Valerie Valenzuela; Jun Wu; Marwan Fakih
Source: check_circle
Crossref

G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway

Molecular Cancer Research
2021-03-01 | Journal article
Contributors: Ting Sun; Keqiang Zhang; Rajendra P. Pangeni; Jun Wu; Wendong Li; Yong Du; Yuming Guo; Shyambabu Chaurasiya; Leonidas Arvanitis; Dan J. Raz
Source: check_circle
Crossref

Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Clinical Cancer Research
2020-03-01 | Journal article
Contributors: Robert Chen; Alex F. Herrera; Jessie Hou; Lu Chen; Jun Wu; Yuming Guo; Timothy W. Synold; Vu N. Ngo; Sandrine Puverel; Matthew Mei et al.
Source: check_circle
Crossref

Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer

Cell Communication and Signaling
2019-12 | Journal article
Part of ISSN: 1478-811X
Source: Self-asserted source
Yuming Guo

Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer

Translational Oncology
2019-08 | Journal article
Part of ISSN: 1936-5233
Source: Self-asserted source
Yuming Guo

Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer

Cells
2019-08-30 | Journal article
Contributors: Wei Wen; Emily Marcinkowski; David Luyimbazi; Thehang Luu; Quanhua Xing; Jin Yan; Yujun Wang; Jun Wu; Yuming Guo; Dylan Tully et al.
Source: check_circle
Crossref